tradmap

ADVB Earnings Advanced Biomed Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$0 -$0 $0 2024 2025
EPS
Net income (annual)
-$3M -$2M $0 2024 2025
Net income
Return on equity (annual)
-167% -84% 0% 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$3 $1 $5 $0 Q4 '23 Q1 '24 Q3 '24 Q4 '24 Q1 '25 Q3 '25 Q4 '25 Q1 '26
EPS
Net income (quarterly)
-$1M $3M $7M $0 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26
Net income
Return on equity (quarterly)
-147% 33% 212% 0% Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26
ROE

Reported EPS history

1–10 of 10
Q3 20262026-03-315.212026-05-1510-Q
Q2 20262025-12-310.302026-02-1310-Q
Q1 20262025-09-30-0.022025-11-1910-Q
FY 20252025-06-30-0.162025-10-0810-K
Q3 20262025-03-31-2.542026-05-1510-Q
Q2 20262024-12-31-0.062026-02-1310-Q
Q1 20262024-09-30-0.012025-11-1910-Q
FY 20252024-06-30-0.142025-10-0810-K
Q3 20252024-03-31-0.102025-05-1510-Q
Q2 20252023-12-31-0.052025-04-1510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.